​

vTv Therapeutics Ownership | Who Owns vTv Therapeutics?

OverviewForecastRevenueFinancialsChart

vTv Therapeutics Ownership Summary

vTv Therapeutics is owned by 19.08% institutional investors, 38.83% insiders, and 42.09% retail investors. Samsara biocapital is the largest institutional shareholder, holding 3.54% of VTVT shares. Fidelity Select Biotechnology is the top mutual fund, with 6.61% of its assets in vTv Therapeutics shares.

VTVT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockvTv Therapeutics19.08%38.83%42.09%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Samsara biocapital298.50K3.54%$11.24M
Millennium management269.87K3.20%$10.16M
Fmr260.39K3.09%$9.80M
Siren163.00K1.94%$6.14M
Baker bros. advisors lp148.31K1.76%$5.58M
Vanguard capital management94.46K1.12%$3.56M
Vanguard group83.40K1.04%$3.34M
Aisling capital management lp50.00K0.59%$1.88M
Marshall wace, llp39.56K0.47%$1.49M
Geode capital management32.47K0.39%$1.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Samsara biocapital298.50K0.92%$11.24M
Aisling capital management lp50.00K0.40%$1.88M
Verdad advisers, lp9.00K0.32%$338.70K
Connective capital management9.71K0.21%$226.78K
Siren163.00K0.12%$6.14M
Integrated quantitative investments8.21K0.05%$309.11K
Baker bros. advisors lp148.31K0.03%$5.58M
China universal asset management2.50K0.01%$94.13K
Valley national advisers980.000.00%$36.90K
Millennium management269.87K0.00%$10.16M

Top Buyers

HolderShares% AssetsChange
Millennium management269.87K0.00%63.59K
Aisling capital management lp50.00K0.40%50.00K
Vanguard group83.40K-36.41K
Marshall wace, llp39.56K0.00%26.17K
Renaissance17.45K0.00%17.45K

Top Sellers

HolderShares% AssetsChange
683 capital management---16.00K
Vanguard capital management94.46K0.00%-14.46K
Goldman sachs group---13.35K
Northern trust6.12K--11.93K
Brevan howard capital management lp---7.53K

New Positions

HolderShares% AssetsChangeValue
Aisling capital management lp50.00K0.40%50.00K$1.88M
Renaissance17.45K0.00%17.45K$657.14K
Jane street group13.70K-13.70K$515.92K
Two sigma investments, lp11.49K0.00%11.49K$432.45K
Verdad advisers, lp9.00K0.32%9.00K$338.70K

Sold Out

HolderChange
Raymond james financial-1.00
Northwestern mutual wealth management-2.00
Jpmorgan chase-3.00
Barclays-36.00
Royal bank of canada-43.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20264425.71%1,607,1428.06%196.12%2321.05%775.00%
Mar 31, 202613-50.00%138,737-89.19%10.65%7-53.33%--100.00%
Dec 31, 202516-30.43%300,228-69.62%31.66%9-18.18%1-66.67%
Sep 30, 202521-978,55266.66%1418.70%1122.22%3-
Jun 30, 2025215.00%587,1232.70%811.82%814.29%4-20.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology260.39K6.61%-
Vanguard Total Stock Mkt Idx Inv60.76K1.54%-13.58K
Vanguard Morn Total Stk Mkt Idx Investor60.76K1.54%-13.58K
Vanguard MStar Total Stk Mkt Idx Invest60.76K1.54%-
Vanguard US Total Market Shares ETF33.45K1.28%-211.00
Vanguard Institutional Extnd Mkt Idx Tr31.40K0.80%-
Fidelity Extended Market Index14.63K0.37%-106.00
iShares Micro-Cap ETF7.14K0.18%-96.00
Extended Equity Market Fund E5.82K0.15%5.82K
Extended Equity Market Fund B5.82K0.15%5.82K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$22.53K
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$30.01K
Nov 18, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$31.27K
Nov 29, 2022FRY JOHN A-Buy$33.77K
Nov 28, 2022FRY JOHN A-Buy$16.97K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q43-

VTVT Ownership FAQ

Who Owns vTv Therapeutics?

vTv Therapeutics shareholders are primarily institutional investors at 19.08%, followed by 38.83% insiders and 42.09% retail investors. The average institutional ownership in vTv Therapeutics's industry, Biotech Stocks , is 379.61%, which vTv Therapeutics falls below.

Who owns the most shares of vTv Therapeutics?

vTv Therapeutics’s largest shareholders are Samsara biocapital (298.5K shares, 3.54%), Millennium management (269.87K shares, 3.20%), and Fmr (260.39K shares, 3.09%). Together, they hold 9.84% of vTv Therapeutics’s total shares outstanding.

Does Blackrock own vTv Therapeutics?

BlackRock is not among the top 10 institutional shareholders of vTv Therapeutics.

Who is vTv Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is vTv Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.92% of its assets in 298.5K vTv Therapeutics shares, valued at 11.24M$.

Who is the top mutual fund holder of vTv Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of vTv Therapeutics shares, with 6.61% of its total shares outstanding invested in 260.39K vTv Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools